SMARCB1 and nasal cavity and paranasal sinus carcinoma: SMARCB1 deficiency in a subset of poorly or undifferentiated sinonasal carcinoma was first recognized in 2014 by 2 independent groups [28, 29] followed by a few additional case series, the largest multi-institutional series comprised 39 patients [30].